Cargando…
Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
Two hundred and twenty patients with progressive advanced breast cancer were given primary endocrine treatment (PET) according to menstrual status. Pre-menopausal patients received ovarian irradiation (O) and post-menopausal tamoxifen 10 mg bd (T). Patients were randomised to receive either no addit...
Autores principales: | Rubens, R. D., Tinson, C. L., Coleman, R. E., Knight, R. K., Tong, D., Winter, P. J., North, W. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246832/ https://www.ncbi.nlm.nih.gov/pubmed/3219274 |
Ejemplares similares
-
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
por: Roberts, M. M., et al.
Publicado: (1978) -
Elastosis and response to endocrine therapy in human breast cancer.
por: Masters, J. R., et al.
Publicado: (1979) -
Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect.
por: Beranek, J. T.
Publicado: (1989) -
Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
por: Tacey, Alexander, et al.
Publicado: (2019) -
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer
por: Houston, S J, et al.
Publicado: (1999)